| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 4 | |
| #3 | Australia | 2 | |
| #4 | Canada | 2 | |
| #5 | China | 2 | |
| #6 | EPO (European Patent Office) | 2 | |
| #7 | Republic of Korea | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Heterocyclic compounds | |
| #5 | Special acyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Burak Eric Steven | 12 |
| #2 | Valliant John Fitzmaurice | 12 |
| #3 | Simms Ryan Wayne | 12 |
| #4 | Forbes John Richard | 6 |
| #5 | Mahoney Stuart James | 6 |
| #6 | Moran Matthew David Burr | 6 |
| #7 | Holash Jocelyn | 4 |
| #8 | Hu Meiduo | 2 |
| #9 | Valliant John | 2 |
| #10 | Burak Eric | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020180898A1 | Methods and compositions for treating cancer | |
| WO2020115556A1 | Radioimmunoconjugates and checkpoint inhibitor combination therapy | |
| EP3619191A1 | Pharmacokinetic enhancements of bifunctional chelates and uses thereof | |
| US2019083662A1 | Igf-1r monoclonal antibodies and uses thereof | |
| US10093741B1 | IGF-1R monoclonal antibodies and uses thereof |